Abstract
Lack of transparency in clinical research is a global problem that has drawn recent attention due the SARS-Cov-2 pandemics. Clinical trials results may be biased by selective publication, publication of partial or fraudulent results, suppression of negative results, publication delay, and even lack of publication of an entire study. Such practices endanger the right to health, undermine evidence-based medicine, and breach the ethical duties of researchers and sponsors. Transparency requires the enactment of uniform laws and joint efforts of all social and political actors involved in health research, in order to comply with the ethical and legal issues surrounding the need for open and clearly designed clinical trials.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
